Home > M&A deals 2015 > Stonebridge Partners acquires Green Cross Biotherapeutics, Inc.
Buyout (LBO, MBO, MBI) · Life Science · January 2015

Stonebridge Partners acquires Green Cross Biotherapeutics, Inc.

On January 1, 2015, Stonebridge Partners acquired Green Cross Biotherapeutics, Inc., a life science company in Quebec, Canada.

Deal at a glance

AnnouncedJanuary 1, 2015 TypeBuyout (LBO, MBO, MBI) TargetGreen Cross Biotherapeutics, Inc. Buyer Stonebridge Partners SectorLife Science LocationQuebec, Canada ValueNot disclosed

Target company

Green Cross Biotherapeutics, Inc.
Quebec, Canada
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Stonebridge Partners
Private equity firm · 33 deals on record
  • 1st transaction in life science
  • 1st transaction in Canada
33deals, all time
1in this sector
2022latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Godwin Formwork Solutions, Inc.Same lead buyer · Apr 2022
Repare Therapeutics, Inc.Same sector and country · Jan 2026
LSK Technologies, Inc.Same sector and country · May 2022
A&L Canada Laboratories, Inc.Same sector and country · May 2022

Questions about this deal

Who acquired Green Cross Biotherapeutics, Inc.?Stonebridge Partners acquired Green Cross Biotherapeutics, Inc. on January 1, 2015.

What type of deal was it?It was a buyout (lbo, mbo, mbi) in the life science sector in 2015.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).